Executive search consultancy, SCi Partners, has announced the appointment of Mark Johnson as Senior Partner.
With a background in manufacturing/quality and development for the vaccine industry, Mark’s expertise has informed his career in executive search for the pharmaceutical, life sciences and healthcare industries, from board level to middle management. Most recently a Partner with a global Life Sciences recruitment business, Mark has spent years focused upon building high-performance leadership and technical teams for fast growing biotechnology and cell & gene therapy companies, gaining a unique skill set and level of expertise in these fields.
Commenting on his appointment, Mark said: “I’m delighted to be joining what I know to be an incredibly dynamic and experienced team. I believe there is a gap in the executive search market for us to partner with the advanced therapies sector, and this constitutes an exciting opportunity for SCi Partners to lead the way in this respect.”
Mark’s appointment reflects the company’s ambition to grow its services to support specialised biotechs access specialised talent.
Dafydd Wright, SCi Managing Partner, said: “Mark has an impeccable reputation within the biotechnology space, with particular emphasis on helping cell and gene companies access top talent. Both his industry and consultancy experience bring a unique perspective to our clients and he is an excellent addition to the team.”
